Purchase Order N6264520P0024
Award Date
5/13/20
Potential Completion Date
5/12/25
Potential Value
$295K
Federal Agency
Defense Health Agency
Awardee
Cerus Corporation
Ultimate Awardee
Not listed
NAICS Category
325413 - In-Vitro Diagnostic Substance Manufacturing
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Agana Heights, Guam
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Cerus Corporation, a biomedical products company specializing in blood safety technologies and pathogen reduction systems. The contract is for the INTERCEPT Platelet Processing Set and service maintenance, with a ceiling value of $193,882.00 and a period of performance from January 14, 2025 to September 30, 2027. The contract stems from a sole-source solicitation for the INTERCEPT Blood System...
This firm fixed-price purchase order contract was awarded by the Defense Health Agency (DHA) to Cerus Corporation, a biomedical products company specializing in blood safety technologies and pathogen reduction systems. The $369,384 contract is for the provision of Cerus' proprietary INTERCEPT Blood System, which uses riboflavin and ultraviolet light to inactivate pathogens in blood components, including platelets and plasma. This pathogen reduction technology plays a critical role in reducing...
This is a firm fixed-price purchase order contract awarded by the Defense Health Agency (DHA) to Cerus Corporation, a biomedical products company specializing in blood safety technologies and pathogen reduction systems. The contract, valued at $214,560.00, is for the delivery of INT2540B DROP SHIPMENT FOR PLATELET PROCESSING. This contract has no set-aside designation. Cerus Corporation is the prime contractor and there are no major subcontractors identified. The contract supports medical...
This is a firm fixed price purchase order contract awarded by the Defense Health Agency to Cerus Corporation, a biomedical products company that manufactures the INTERCEPT Blood System technology for pathogen reduction in blood components. The contract is for the DROP SHIPMENT OF INTERCEPT DUAL, with a potential value of $66,624.00 and a completion date of January 1, 2024. Cerus Corporation, the prime contractor, is a for-profit manufacturer that has received over 20 federal contract awards from...
This is a firm fixed-price purchase order contract awarded by the National Institutes of Health (NIH) Clinical Center to Cerus Corporation, a biomedical products company specializing in blood safety technologies. The contract is for a Preventative Maintenance Agreement for the INTERCEPT Blood System Illuminators, with a period of performance from July 15, 2025, to July 14, 2026, and a ceiling value of $15,372.00. The contract does not have a set-aside designation. Cerus Corporation is the...
This federal contract award is for the delivery of medical supplies, specifically PLATELET COLLECTION, to the Defense Logistics Agency (DLA), which is part of the U.S. Department of Defense. The contract was awarded to Cardinal Health 200, LLC, a subsidiary of the global healthcare services and products company Cardinal Health, Inc. The contract has a ceiling value of $35,227.82 and is a firm fixed-price delivery order under an existing Indefinite Delivery Contract (IDC) with the DLA,...
This is a firm-fixed price purchase order awarded by the Defense Health Agency (DHA) to Haemonetics Corporation, a leading provider of blood and plasma supplies and services, for $30,688.30. The contract is for blood consumable supplies such as blood bags, tubing sets, reagents, and solutions. The award has an ultimate completion date of August 1, 2022 and does not utilize a set-aside. Haemonetics is the prime contractor and no subcontractors are identified. The DHA, which delivers integrated...
This federal contract award is for the delivery of TRIMA ACCEL RBC/PLATELET/PLASMA SET to the Defense Health Agency, an agency within the Department of Defense that provides health services to the U.S. military. The contract, valued at $61,092.72, was awarded to the prime contractor Terumo BCT Inc., a foreign-owned, for-profit manufacturer of medical devices and provider of blood and cell technology services. The contract is a firm fixed-price delivery order with a completion date of December 5,...
This is a $81,259.56 firm fixed-price purchase order contract awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Terumo BCT Inc., a foreign-owned manufacturer of medical devices and blood processing equipment. The contract is for the delivery of PLATELET SET products, and is designated as a total small business set-aside. Terumo BCT Inc., operating as Terumo Bct, Inc. Division and doing business as Caridianbct, has a strong track record of providing...
This $67,003.20 firm-fixed price purchase order was awarded by the Bureau of Medicine and Surgery, a component of the Department of Defense, to Haemonetics Corporation, a leading provider of blood and plasma management products and services. The contract does not have a set-aside designation. The award is for the delivery of 0236-00 items as described in the contract, likely blood processing equipment and consumables. Haemonetics is an established medical device manufacturer that has received...